A prediction model of risk factors for complications among SARS-CoV2 positive patients: Cases from Jordan

Autor: Mohanad M. Odeh, Rami Al Qaissieh, Amjed A. Tarifi, Muna M. Kilani, Ramzy E. Tadros, Abedrazzaq I. Al khashman, Karem H. Alzoubi

Publikováno v: Journal of Infection and Public Health, Vol 14, Iss 6, Pp 689-695 (2021)

Background: The number of COVID-19 infected patients has been soaring in the Middle East countries.The disease poses a significant threat, decisions about prioritizing care should be made in accordance with the proven risk factors for complications.

Externí odkaz: https://doaj.org/article/a2bc44d4a1a0415c8dbd2b14eea82484

Transoral Endoscopic Resection of Oropharyngeal Pedunculated Giant Fibrolipoma Using Harmonic Scalpel: A Case Report

Autor: Amjed A. Tarifi, Bara’ H. Al-qutiesh, Khaled H. Badran, Heba H. Al-mallah, Jesus E. Medina

Publikováno v: Ear, nose,throat journal.

Lipoma is the most common soft tissue benign tumor in the body. It can occur in the head and neck area as well. Fibrolipoma is a variant of lipoma that contains fibrous tissue. Fibrolipomas of the head and neck are relatively rare, and their presenta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e23387d93e7fc8f8afe89eac21939df6
https://pubmed.ncbi.nlm.nih.gov/35324367

Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers

Autor: Farah Abo Domaidah, Aiman Suleiman, Lara Shdaifat, Haneen Abu Jaber, Mohammad Rashid Al-Zarir, Amjed A. Tarifi, Heba Alsmadi, Isam Bsisu, Sami A. Abu-Halaweh, Abeer Santarisi, Ahmed Al Sharqawi, Abdel-Ellah Al-Shudifat, Hadeel Alnawaiseh, Rami Alqassieh, Yara Anasweh, Omar Shatnawi, Mohammad Al-Tamimi

Publikováno v: Vaccines
Volume 9
Issue 11
Vaccines, Vol 9, Iss 1223, p 1223 (2021)

COVID-19 (coronavirus disease 2019) vaccines induce immunity through different mechanisms. The aim of this study is to compare the titers of specific antibodies in subjects vaccinated with either the Pfizer-BioNTech COVID-19 vaccine or the Sinopharm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a4a17a1e83bdc2a3e158e2e7cd4c5e

A prediction model of risk factors for complications among SARS-CoV2 positive patients: Cases from Jordan

Autor: Abedrazzaq I. Al khashman, Muna M Kilani, Mohanad Odeh, Karem H. Alzoubi, Ramzy Edward Tadros, Amjed A. Tarifi, Rami Al Qaissieh

Publikováno v: Journal of Infection and Public Health, Vol 14, Iss 6, Pp 689-695 (2021)
Journal of Infection and Public Health

Background The number of COVID-19 infected patients has been soaring in the Middle East countries. The disease poses a significant threat, decisions about prioritizing care should be made in accordance with the proven risk factors for complications.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd61d764211650ec2eb3413b5cb81755
https://pubmed.ncbi.nlm.nih.gov/33984658

Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers.

Autor: Alqassieh R; Department of General and Specialized Surgery, Faculty of Medicine, The Hashemite University, Zarqa 13133, Jordan., Suleiman A; Beth Israel Deaconess Medical Center, Anesthesia and Intensive Care Department, Harvard Medical School, Boston, MA 02215, USA., Abu-Halaweh S; Department of Anesthesia and Intensive Care, School of Medicine, The University of Jordan, Amman 11942, Jordan., Santarisi A; Department of Emergency Medicine and Accidents, School of Medicine, The University of Jordan, Amman 11942, Jordan., Shatnawi O; Department of Cancer Biology, Wake Forest School of Medicine and Wake Forest Baptist Health, Winston-Salem, NC 27157, USA., Shdaifat L; School of Medicine, Mutah University, Karak 61710, Jordan., Tarifi A; Department of General and Specialized Surgery, Faculty of Medicine, The Hashemite University, Zarqa 13133, Jordan., Al-Tamimi M; Faculty of Medicine, The Hashemite University, Zarqa 13133, Jordan., Al-Shudifat AE; Faculty of Medicine, The Hashemite University, Zarqa 13133, Jordan., Alsmadi H; Department of Anesthesia and Intensive Care, School of Medicine, The University of Jordan, Amman 11942, Jordan., Al Sharqawi A; Department of Anesthesia and Intensive Care, School of Medicine, The University of Jordan, Amman 11942, Jordan., Alnawaiseh H; Department of Anesthesia and Intensive Care, School of Medicine, The University of Jordan, Amman 11942, Jordan., Anasweh Y; Department of Anesthesia and Intensive Care, School of Medicine, The University of Jordan, Amman 11942, Jordan., Domaidah FA; Department of Anesthesia and Intensive Care, School of Medicine, The University of Jordan, Amman 11942, Jordan., Jaber HA; Department of Anesthesia and Intensive Care, School of Medicine, The University of Jordan, Amman 11942, Jordan., Al-Zarir MR; Department of Anesthesia and Intensive Care, School of Medicine, The University of Jordan, Amman 11942, Jordan., Bsisu I; Department of Anesthesia and Intensive Care, School of Medicine, The University of Jordan, Amman 11942, Jordan.

Publikováno v: Vaccines [Vaccines (Basel)] 2021 Oct 21; Vol. 9 (11). Date of Electronic Publication: 2021 Oct 21.